Abstract: According to an aspect of the present disclosure, a hand held device is providing twelve lead ECG signals using fewer number of probes/electrodes comprising, a first electrode to sense electrical RH signal, a second electrode to sense electrical LH signal, a third electrode to sense electrical LL signal, a fourth electrode to sense electrical V1 through V6 signal in a sequence, a first electronic circuit operative generate a lead I, lead II and lead III ECG signal, a second electronic circuit to generate a CT signal from the lead I, lead II and lead III signal and a third electronic circuit operative to generate V1-V6 lead ECG signals from the electrical V1 through V6 signal and the CT signal.
Claims:CLAIMS
I/We Claim,
1. A hand held device providing twelve lead ECG signals using fewer number of
probes/electrodes comprising:
a first electrode to sense electrical RH (right hand) signal;
a second electrode to sense electrical LH (left hand)signal;
a third electrode to sense electrical LL (left leg) signal;
a fourth electrode to sense a set of electrical V1 through V6 signals in a sequence;
a first electronic circuit operative generate a lead I, lead II and lead III ECG signals;
a second electronic circuit to generate a CT signal from the lead I, lead II and lead III
signals; and
a third electronic circuit operative to generate a set of V1-V6 lead ECG signals from the
set of electrical V1 through V6 signals and the CT signal.
2. The hand held device of claim 1, further comprising an enclosure housing the first
electronic circuit, the second electronic circuit and the third electronic circuit, in that, the
first electrode, the second electrode, the third electrode and the fourth electrodes are
formed as a touch pads on outer surface of the enclosure such that, at least two touch pads
are formed on different sides of the enclosure.
3. The hand held device of claim 2, wherein the second electronic circuit is configured to
perform operation represented by a relation: CT = (RA+LA+LL)/3 and the CT value is
stored in a memory in a digital format.
4. The hand held device of claim 3, wherein the third electronic circuit is configured to
perform sequential operation representing the relation: Lead V1 signal =V1 - CT, Lead
V2 signal =V2 - CT, Lead V3 signal =V3 - CT, Lead V4 signal =V4 - CT, Lead V5
signal =V5 - CT, and Lead V6 signal =V6 – CT.
5. Method, system and apparatus providing one or more features as described in the
paragraphs of this specification. , Description:Form 2
The patent Act 1970
(39 of 1970)
AND
Patent Rules 2003
Complete Specification
(Sec 10 and Rule 13)
Title:
METHOD, SYSTEM AND DEVICE FOR GENERATING
ELECTRO CARDIO GRAM WITH FEWER NUMBER OF
PROBES
Applicant(s) Sensesemi Technologies Private Limited
Nationality India
Address BNMIT incubation Center,12th Main, 27th Cross,
Banashankari II stage,Bengaluru,Karnataka,India-560070
The following specification particularly describes the invention and manner in
which it is to be performed.
2
DESCRIPTION
FIELD OF INVENTION
[0001] Embodiments of the present disclosure relate generally to biomedical electronic devices
and more particularly to method, system and device for generating electrocardiogram with fewer
number of probes.
RELATED ART
[0002] Electro cardio gram (ECG) also referred to as EKG is a recording of electrical activity of a
human heart. As is well known, several clinical devices and apparatus are employed to measure
the electrical activity of the heart and represent the measured electrical signal in the form of ECG.
The conventional clinical ECG devices and systems employ number of probes to measure
electrical activity and provide twelve leads ECG signals.
[0003] The 12 leads of the ECG are recognized as lead I, II, III, aVR, aVL, aVF, V1, V2, V3, V4,
V5, and V6 as is well known in the art. Details of generating conventional twelve leads ECG
signals from probes (also referred to as Electrodes) and position of the probes on the human body
etc., are more fully described in a book titled “Bioelectromagnetism - Principles and Applications
of Bioelectric and Biomagnetic Fields”, authored by Jaakko Malmivuo and Robert Plonsey,
published by Oxford University Press, which is incorporated herein by reference. Briefly, the 10
probes/electrodes are provided for measuring electrical activity of the heart.
[0004] The 10 probes are classified as 4 limb (or extremities) electrodes and 6 Precardial (or
chest) electrodes. The four limb electrodes are Right Arm (RA), Left Arm (LA), left Leg (LL) and
Right Leg (RL). In some cases, the RL probe on the right leg is connected/ considered as
reference electrode (reference potential) thereby requiring only 9 probes for measuring the
electrical signals. Electrical signal measured by RA, LA and LL probes are used to capture signal
and derive leads I, II, III, aVR, aVL, and aVF signals. Further, an additional reference potential
referred to as Wilson central terminal (CT) is formed by connecting a resistance to each limb
electrode and interconnecting the free end of the wires to form the CT common point. The CT
common point or (Wilson central terminal) represents an average of the limb potentials aVR,
aVL, and aVF. The 6 precardial probes are positioned/ placed on the chest around the heart in a
known way. The electrical signal measured by the 6 precardial probes is used to provide six leads
3
(V1- V6) ECG signals. As may be seen, in order to provide all twelve leads signals (I, II, III,
aVR, aVL, aVF, and V1- V6), the 10 electrodes (LA, RA, RL, LL, and V1-V6) need to be placed
at the appropriate positions. Since these are physically at distant locations, 10 separate cables are
usually employed making it cumbersome and complicated procedure at least for preliminary
diagnostics.
SUMMARY
[0005] According to an aspect of the present disclosure, a hand held device is providing twelve
lead ECG signals using fewer number of probes/electrodes comprising, a first electrode to sense
electrical RH signal, a second electrode to sense electrical LH signal, a third electrode to sense
electrical LL signal, a fourth electrode to sense electrical V1 through V6 signal in a sequence, a
first electronic circuit operative generate a lead I, lead II and lead III ECG signal, a second
electronic circuit to generate a CT signal from the lead I, lead II and lead III signal and a third
electronic circuit operative to generate V1-V6 lead ECG signals from the electrical V1 through
V6 signal and the CT signal.
[0006] Several aspects are described below, with reference to diagrams. It should be understood
that numerous specific details, relationships, and methods are set forth to provide a full
understanding of the present disclosure. One who skilled in the relevant art, however, will readily
recognize that the present disclosure can be practiced without one or more of the specific details,
or with other methods, etc. In other instances, well-known structures or operations are not shown
in detail to avoid obscuring the features of the present disclosure.
BRIEF DESCRIPTION OF DRAWINGS
[0007] FIG. 1 is an example device providing twelve lead ECG signal using fewer number of
probes/electrodes in an embodiment.
[0008] FIG. 2 is a block diagram illustrating an example generation of twelve leads ECG signals
from four electrodes.
[0009] FIG. 3A is a block diagram illustrating the manner in which the leads I and II ECG
signals are generated.
[0010] FIG. 3B is a block diagram illustrating the manner in which CT signal is generated in one
embodiment.
[0011] FIG. 4 is a block diagram illustrating the manner in which lead V1-V6 signals are
generated in one embodiment.
4
[0012] FIG. 5 is a block diagram of a hand held device generating twelve lead ECG signals in
one embodiment.
DETAILED DESCRIPTION OF THE PREFERRED EXAMPLES
[0013] FIG. 1 is an example device providing twelve lead ECG signal using fewer number of
probes/electrodes in an embodiment. The device 101 is shown comprising probes (electrodes)
110, 120, 130, and 140, 12 lead ECG generator 150, and output interface 160. Each element is
described in further detail below.
[0014] The probes 110, 120, and 130 are operative as limb electrodes to sense electrical signals
on LA, RA and LL. In one embodiment, the 110, 120, and 130 probes are configured to receive
electrical signal through one finger on the left arm, one finger on the right arm and upper part of
the left leg respectively. Due to such configuration, the three probes 110, 120, and 130 may be
mounted close to each other as fingers on both hands may easily reach the upper left leg part.
[0015] The probe 140 is flexible or movable probe that may be placed at multiple positions. In
that, the probe 140 is configured to be placed over the chest at the positions corresponding to the
leads V1 through V6 of the twelve leads ECG signals. Thus, probe 140 operates as precardial
electrode. Accordingly, the probe 140 collects electrical signals for leads V1 through V6. In one
embodiment, the probe 140 comprises single probe/electrode configured to place at positions V1
through V6 in a sequential manner. Thus, the probe 140 senses anyone of V1 through V6 at a
given point in time. Alternatively, the probe 140 may comprise a set of electrodes in the form of a
patch and may sense more than one of V1 through V6 leads simultaneously.
[0016] The 12 lead ECG generator 150 generates twelve leads ECG signals I, II, III, aVR, aVL,
aVF, and V1 through V6 from the electrical signal captured by the probes 110, 120, 130, and
140. The twelve leads ECG signals are provided to the output interface 160. The output interface
160 may comprise plotter, electronic display device, memory and other electronic system, for
example, configured to plot/display/store/apply the 12 leads ECG signals. The manner in which
the 12 lead ECG generators 150 generates twelve leads ECG signal from the fewer probes (110,
120, 130, 140 for example) is further described below.
[0017] FIG. 2 is a block diagram illustrating a generation of twelve leads ECG signals from four
electrodes. In block 210, the 12 lead ECG generator receives RL, RH and LL electrode signal
through three probes. In block 220, the 12 lead ECG generator generates leads I, II, III, aVR,
aVL, and aVF signals.
5
[0018] In block 230, the 12 lead ECG generator generates CT signal. In one embodiment, the CT
signal is determined as an average of the potential measured by probes 110, 120, 130. In block
240, the 12 lead ECG generator, stores the CT signal in a memory. In block 250, the 12 lead
ECG generator generates leads V1 through V6 signals as difference between the potential
measured by the probe 140 and stored CT signal. In one embodiment, the leads V1 through V6
signals are generated sequentially when the probe 140 is sequentially placed over positions
corresponding to V1 through V6 on the chest. As a result, the twelve lead ECG signals are
generated without having to hold more than 3 probes at any given time. This enables a user to
generate twelve lead ECG signals by self. The manner in which the 12 lead ECG generator may
be implemented is further described below.
[0019] FIG. 3A is a block diagram illustrating the manner in which the leads I and II ECG
signals are generated. The block diagram is shown comprising differential amplifiers 310A and
310B, analog to digital convertors (ADC) 320A and 320B, and digital filters 330A and 330B. In
the block diagram, probe 301 sensing LA is coupled to the non inverting terminal and the probe
302 sensing RA is coupled to the inverting terminal of the differential amplifier 310A. Similarly,
probe 303 sensing LL is coupled to the non inverting terminal and the probe 302 sensing RA is
coupled to the inverting terminal of the differential amplifier 310B. The differential amplifier
310A amplifies the difference LA-RA to generate lead I ECG signal on path 312A. Similarly, the
differential amplifier 310B amplifies the difference LL-RA to generate lead II ECG signal on
path 312B.
[0020] The analog to digital convertor (ADC) 320A and 320B respectively converts the lead I
ECG signal and lead II ECG signal to respective digital bit streams. In one embodiment, a sigmadelta
modulator is employed for converting the analog lead I and lead II ECG signals to digital
lead I and lead II ECG signals. The digitized bit streams from ADC 320A and B are provided on
path 323A and B. The digital filter 330A and B respectively filters the bit streams 323A and B to
eliminate the noise. For example, noise introduced by the electronic components, electrodes,
probes etc are filtered by the digital filter 330A and B. The filtered lead I and lead II ECG
signals in the digital domain are provided on path 339A and B respectively.
[0021] In one embodiment the lead III ECG signal is generated by subtracting lead I ECG signal
from the lead II ECG signal (Lead III = Lead II -Lead I). The subtraction operation may be
performed on the analog lead1 and lead II ECG signal on the path 312 A and B. Alternatively the
6
subtraction operation may be performed in the digital domain using the digital signals on paths
339A and B.
[0022] FIG. 3B is a block diagram illustrating the manner in which CT signal is generated in one
embodiment. The block diagram is shown comprising buffers 340A-E, resistors 350A-E,
capacitor 355, amplifier 360, ADC 370, filter 380 and memory 390. The block diagram is further
described in detail below.
[0023] In the block diagram, the buffers 340A-C provide a high impedance coupling to the
signals LA, RA, and LL sensed by the probes 301, 302, and 303 respectively. The buffers 340AC
may be implemented by employing operational amplifier in the non inverting mode with unity
gain. The resistors 350A-C in combination with buffer 340D operate to add the LA, RA, and LL
signal to provide summed RA+LA+LL signal on path 354 and 356. The buffer 340E, the
capacitor 355 and resistor 350D together operate as low pass filter and provide a reference signal
(which is filtered and inverted signal of common mode signals of RA+LA+LL). The reference
signal is tied to RL probe to cancel out the common mode noise and also provide a DC bias to
the Amplifiers.
[0024] The amplifier 360, receives the summed RA+LA+LL signal on its non inverting terminal
and the reference signal (tied to RL) on the inverting terminal to generate CT signal on path 367.
The ADC 370, converts the analog CT signal on path 367 to digital stream. In one embodiment
the ADC 370 is implemented as delta sigma modulator. The CT digital signal is provided on path
378. The filter 380 operates to filter the noise in the CT signal to generate noise free CT signal.
The noise free CT signal digital values are stored in the memory 390 (the memory may be an
internal memory, Flash memory, RAM, Hard disk, etc.). In one embodiment, the resistors 350AC
are set to 200K Ohms, 350D is set to 100K ohms and 350E is set to 1M ohms. The capacitor
355 is set to 1.5 nanofarad.
[0025] FIG. 4 is a block diagram illustrating the manner in which lead V1-V6 signals are
generated in one embodiment. The block diagram is shown comprising differential amplifiers
410, analog to digital convertors (ADC) 420, digital filters 430 and digital to analog converter
(DAC) 440. In the block diagram, probe 401 is configured to sense electrical signals around
chest area at positions V1-V6. The probe 401 is coupled to the non inverting terminal of the
differential amplifier 410. The DAC 440 converts the CT signal stored in the memory 390 to
analog CT signal and provides on the path 441 that is coupled to the inverting terminal of the
7
differential amplifier 410. The differential amplifier 410 amplifies the difference of signal sensed
by probe 401 and the analog CT signal on path 441 to generate lead signals V1 through V6 ECG
signals on path 412.
[0026] The analog to digital convertor (ADC) 420 converts the V1 through V6 ECG signals on
path 412 to digital bit streams. In one embodiment, a sigma-delta modulator is employed for
converting. The digitized bit streams from ADC 420 are provided on path 423. The digital filter
430 filters the bit streams 423 to eliminate the noise. The filtered V1 through V6 ECG leads
signals in the digital domain are provided on path 439. In one embodiment, a timer is employed
to indicate the successful detection and conversion of the signal sensed by the probe 301-303,
401 for predetermined time period at their respective position. The corresponding one or more of
the 12 lead ECG signal is stored/buffered for presenting the twelve lead ECG signal.
[0027] Accordingly, the lead I, II are provided on path 339A and B, the lead III signal is
provided by employing a subtractor (not shown) as Lead III = Lead II - Lead I, the CT signal is
stored in the memory 390, and the V1-V6 signals are provided on path 432 in sequence as per the
positioning of the probe 401. The manner in which leads aVR, aVL and aVF may be generated in
the 12 leads ECG signal generator 150 is further described below.
[0028] The 12 leads ECG signal generator 150 employ adder, subtractor and divider circuitry to
generate the aVR, aVL and aVF in an embodiment. The lead signal aVR is generated through
electronic circuitry that perform operation as: aVR= -(lead I + Lead II) / 2. Similarly, aVL and
aVF are generated using relations: aVL = (lead I - lead II/2) and aVF = (lead II – lead I/2). Thus
generating twelve leads ECG signal from four probes (like 101-104 or 301-303 and 401).
[0029] The manner in which device 101 is employed for generating the twelve lead ECG signals
in en embodiment is further described below.
[0030] FIG. 5 is a block diagram of a hand held device generating twelve lead ECG signals in
one embodiment. The device 501 is shown comprising stage selector button 510, electrode pads
520A- 520D, package 530, beeper 540 and display 550. Each element is further described below.
[0031] The electrode pads 520A-520D are shown mounted on the surface of the package 530.
The package 530 houses the elements described in sections above. The electrode pads 520A-C
are respectively is coupled to the probes 301, 302, and 303. Alternatively, the pads 520A-C may
operate as probes 301, 302, and 303. In that, electrode pads 520A and 520B are mounted on the
two opposite side surface of the package 530 and the electrode pad 520C is mounted on the
8
bottom side of the package 530. The pad 520D is mounted on the top surface of the package
530 and is coupled to the probe 401. Alternatively, the electrode pad 520D may operate as the
probe 401. The selection button 510 enable selection stages and/or switching from one stage to
other. Beeper 540 provides audio signal indicating completion of an operation as described in
the sections below. The display 550 provides the twelve lead ECG signals and also other guiding
indications for operations. The manner in which the device 501 may be operated is further
described below
[0032] In operation, the button 510 is pressed to select stage one operations. The selection of
stage one operation may be confirmed on the display by pressing the button 510. When in the
stage one, the user may place the right hand thumb on the pad 520A, left hand thumb on the pad
520B and the bottom pad 520C on the thigh together. The beeper 540 send out a beep signal to
indicate successful capturing and generation of lead 1, II, III, aVL, aVR, aVF and storing of CT
signal in the memory. After receiving the beeper sound the user may release the thumbs and
thigh from the respective pads and operate button 510 again to select the stage two operation.
The selection of stage two operation may be confirmed on the display by pressing the button
510.
[0033] On successful selection of the stage two operations, user may place device on the chest
such that the pad 520D makes contact at position V1. The beeper 540 sends out a beep on
successful capturing of the electrical signal from position V1 and generation of V1 lead signal.
The user may move/slide the device 501 such that the pad 520D make contact at position V2 to
generate the V2 lead signal. In a similar way, on each beep signal, user may slide the device to
make contact at V3-V6 positions on successive beeps to generate lead V3-V6 signals. The
selection button may be operated to show the result on the display. On pressing the button 530
for display, the device 501 presents twelve leads ECG signals on the display device.
[0034] The number of buttons, and beeps and or sound may be employed to provide more varied
selection information, positioning information, etc. for example, device 501 may be employed to
detect the positioning of the electrode accurately by comparing the signal, signal strength with
stored reference signal, or history of the data stored successively. In an yet another alternative,
the electrode pad 520D may be made flexibly pulled out of the package 530 to place the pad 520
on the chest while seeing the display. All such extension of the implementation that are apparent
9
to a person skilled in the art by reading this disclosure is covered by this disclosure and the
claims.
[0035] While various embodiments of the present disclosure have been described above, it should
be understood that they have been presented by way of example only, and not limitation. Thus,
the breadth and scope of the present disclosure should not be limited by any of the abovediscussed
embodiments, but should be defined only in accordance with the following claims and
their equivalents.
| # | Name | Date |
|---|---|---|
| 1 | 201941042812-ABSTRACT [22-02-2024(online)].pdf | 2024-02-22 |
| 1 | 201941042812-Correspondence to notify the Controller [16-04-2025(online)].pdf | 2025-04-16 |
| 1 | 201941042812-STATEMENT OF UNDERTAKING (FORM 3) [22-10-2019(online)].pdf | 2019-10-22 |
| 2 | 201941042812-CLAIMS [22-02-2024(online)].pdf | 2024-02-22 |
| 2 | 201941042812-PROOF OF RIGHT [22-10-2019(online)].pdf | 2019-10-22 |
| 2 | 201941042812-US(14)-HearingNotice-(HearingDate-30-04-2025).pdf | 2025-04-16 |
| 3 | 201941042812-ABSTRACT [22-02-2024(online)].pdf | 2024-02-22 |
| 3 | 201941042812-COMPLETE SPECIFICATION [22-02-2024(online)].pdf | 2024-02-22 |
| 3 | 201941042812-POWER OF AUTHORITY [22-10-2019(online)].pdf | 2019-10-22 |
| 4 | 201941042812-FORM FOR SMALL ENTITY(FORM-28) [22-10-2019(online)].pdf | 2019-10-22 |
| 4 | 201941042812-CORRESPONDENCE [22-02-2024(online)].pdf | 2024-02-22 |
| 4 | 201941042812-CLAIMS [22-02-2024(online)].pdf | 2024-02-22 |
| 5 | 201941042812-FORM FOR SMALL ENTITY [22-10-2019(online)].pdf | 2019-10-22 |
| 5 | 201941042812-DRAWING [22-02-2024(online)].pdf | 2024-02-22 |
| 5 | 201941042812-COMPLETE SPECIFICATION [22-02-2024(online)].pdf | 2024-02-22 |
| 6 | 201941042812-FORM 1 [22-10-2019(online)].pdf | 2019-10-22 |
| 6 | 201941042812-FER_SER_REPLY [22-02-2024(online)].pdf | 2024-02-22 |
| 6 | 201941042812-CORRESPONDENCE [22-02-2024(online)].pdf | 2024-02-22 |
| 7 | 201941042812-OTHERS [22-02-2024(online)].pdf | 2024-02-22 |
| 7 | 201941042812-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [22-10-2019(online)].pdf | 2019-10-22 |
| 7 | 201941042812-DRAWING [22-02-2024(online)].pdf | 2024-02-22 |
| 8 | 201941042812-EVIDENCE FOR REGISTRATION UNDER SSI [22-10-2019(online)].pdf | 2019-10-22 |
| 8 | 201941042812-FER_SER_REPLY [22-02-2024(online)].pdf | 2024-02-22 |
| 8 | 201941042812-FORM 3 [21-02-2024(online)].pdf | 2024-02-21 |
| 9 | 201941042812-DRAWINGS [22-10-2019(online)].pdf | 2019-10-22 |
| 9 | 201941042812-FER.pdf | 2023-09-20 |
| 9 | 201941042812-OTHERS [22-02-2024(online)].pdf | 2024-02-22 |
| 10 | 201941042812-COMPLETE SPECIFICATION [22-10-2019(online)].pdf | 2019-10-22 |
| 10 | 201941042812-FORM 18 [16-03-2023(online)].pdf | 2023-03-16 |
| 10 | 201941042812-FORM 3 [21-02-2024(online)].pdf | 2024-02-21 |
| 11 | 201941042812-FER.pdf | 2023-09-20 |
| 11 | 201941042812-Response to office action [01-02-2021(online)].pdf | 2021-02-01 |
| 11 | Correspondence by Agent_Form1_28-10-2019.pdf | 2019-10-28 |
| 12 | 201941042812-EVIDENCE FOR REGISTRATION UNDER SSI [29-01-2021(online)].pdf | 2021-01-29 |
| 12 | 201941042812-FORM 18 [16-03-2023(online)].pdf | 2023-03-16 |
| 12 | 201941042812-FORM 3 [05-09-2020(online)].pdf | 2020-09-05 |
| 13 | 201941042812-Response to office action [01-02-2021(online)].pdf | 2021-02-01 |
| 13 | 201941042812-REQUEST FOR CERTIFIED COPY [29-01-2021(online)].pdf | 2021-01-29 |
| 13 | 201941042812-FORM FOR SMALL ENTITY [29-01-2021(online)].pdf | 2021-01-29 |
| 14 | 201941042812-EVIDENCE FOR REGISTRATION UNDER SSI [29-01-2021(online)].pdf | 2021-01-29 |
| 14 | 201941042812-FORM28 [29-01-2021(online)].pdf | 2021-01-29 |
| 15 | 201941042812-FORM FOR SMALL ENTITY [29-01-2021(online)].pdf | 2021-01-29 |
| 15 | 201941042812-REQUEST FOR CERTIFIED COPY [29-01-2021(online)].pdf | 2021-01-29 |
| 16 | 201941042812-EVIDENCE FOR REGISTRATION UNDER SSI [29-01-2021(online)].pdf | 2021-01-29 |
| 16 | 201941042812-FORM 3 [05-09-2020(online)].pdf | 2020-09-05 |
| 16 | 201941042812-FORM28 [29-01-2021(online)].pdf | 2021-01-29 |
| 17 | Correspondence by Agent_Form1_28-10-2019.pdf | 2019-10-28 |
| 17 | 201941042812-REQUEST FOR CERTIFIED COPY [29-01-2021(online)].pdf | 2021-01-29 |
| 17 | 201941042812-Response to office action [01-02-2021(online)].pdf | 2021-02-01 |
| 18 | 201941042812-FORM 3 [05-09-2020(online)].pdf | 2020-09-05 |
| 18 | 201941042812-FORM 18 [16-03-2023(online)].pdf | 2023-03-16 |
| 18 | 201941042812-COMPLETE SPECIFICATION [22-10-2019(online)].pdf | 2019-10-22 |
| 19 | 201941042812-DRAWINGS [22-10-2019(online)].pdf | 2019-10-22 |
| 19 | 201941042812-FER.pdf | 2023-09-20 |
| 19 | Correspondence by Agent_Form1_28-10-2019.pdf | 2019-10-28 |
| 20 | 201941042812-COMPLETE SPECIFICATION [22-10-2019(online)].pdf | 2019-10-22 |
| 20 | 201941042812-EVIDENCE FOR REGISTRATION UNDER SSI [22-10-2019(online)].pdf | 2019-10-22 |
| 20 | 201941042812-FORM 3 [21-02-2024(online)].pdf | 2024-02-21 |
| 21 | 201941042812-OTHERS [22-02-2024(online)].pdf | 2024-02-22 |
| 21 | 201941042812-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [22-10-2019(online)].pdf | 2019-10-22 |
| 21 | 201941042812-DRAWINGS [22-10-2019(online)].pdf | 2019-10-22 |
| 22 | 201941042812-EVIDENCE FOR REGISTRATION UNDER SSI [22-10-2019(online)].pdf | 2019-10-22 |
| 22 | 201941042812-FER_SER_REPLY [22-02-2024(online)].pdf | 2024-02-22 |
| 22 | 201941042812-FORM 1 [22-10-2019(online)].pdf | 2019-10-22 |
| 23 | 201941042812-DRAWING [22-02-2024(online)].pdf | 2024-02-22 |
| 23 | 201941042812-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [22-10-2019(online)].pdf | 2019-10-22 |
| 23 | 201941042812-FORM FOR SMALL ENTITY [22-10-2019(online)].pdf | 2019-10-22 |
| 24 | 201941042812-FORM FOR SMALL ENTITY(FORM-28) [22-10-2019(online)].pdf | 2019-10-22 |
| 24 | 201941042812-FORM 1 [22-10-2019(online)].pdf | 2019-10-22 |
| 24 | 201941042812-CORRESPONDENCE [22-02-2024(online)].pdf | 2024-02-22 |
| 25 | 201941042812-COMPLETE SPECIFICATION [22-02-2024(online)].pdf | 2024-02-22 |
| 25 | 201941042812-FORM FOR SMALL ENTITY [22-10-2019(online)].pdf | 2019-10-22 |
| 25 | 201941042812-POWER OF AUTHORITY [22-10-2019(online)].pdf | 2019-10-22 |
| 26 | 201941042812-CLAIMS [22-02-2024(online)].pdf | 2024-02-22 |
| 26 | 201941042812-FORM FOR SMALL ENTITY(FORM-28) [22-10-2019(online)].pdf | 2019-10-22 |
| 26 | 201941042812-PROOF OF RIGHT [22-10-2019(online)].pdf | 2019-10-22 |
| 27 | 201941042812-ABSTRACT [22-02-2024(online)].pdf | 2024-02-22 |
| 27 | 201941042812-POWER OF AUTHORITY [22-10-2019(online)].pdf | 2019-10-22 |
| 27 | 201941042812-STATEMENT OF UNDERTAKING (FORM 3) [22-10-2019(online)].pdf | 2019-10-22 |
| 28 | 201941042812-PROOF OF RIGHT [22-10-2019(online)].pdf | 2019-10-22 |
| 28 | 201941042812-US(14)-HearingNotice-(HearingDate-30-04-2025).pdf | 2025-04-16 |
| 29 | 201941042812-Correspondence to notify the Controller [16-04-2025(online)].pdf | 2025-04-16 |
| 29 | 201941042812-STATEMENT OF UNDERTAKING (FORM 3) [22-10-2019(online)].pdf | 2019-10-22 |
| 30 | 201941042812-PETITION UNDER RULE 137 [06-05-2025(online)].pdf | 2025-05-06 |
| 31 | 201941042812-Written submissions and relevant documents [14-05-2025(online)].pdf | 2025-05-14 |
| 32 | 201941042812-PatentCertificate23-05-2025.pdf | 2025-05-23 |
| 33 | 201941042812-IntimationOfGrant23-05-2025.pdf | 2025-05-23 |
| 34 | 201941042812-FORM FOR SMALL ENTITY [16-08-2025(online)].pdf | 2025-08-16 |
| 1 | 201941042812SEARCHSTRATERGYE_18-09-2023.pdf |